ORTHOPHAR
0879.711.212 · rovalta.com · 24/09/2026
ORTHOPHAR
Overview
What does ORTHOPHAR do?
ORTHOPHAR is a Private limited company incorporated in 2006. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Kortrijk.
8510 Kortrijk · FlandreSee on map
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 3,8 k € | -76.8% | 16,4 k € | +9828% | 165 € | -98.4% | 10,4 k € | -15.9% | 12,4 k € | -85.5% | 85,7 k € | -14.5% | 100,3 k € | +233% | 30,1 k € | -87.5% | 240,8 k € | -26.7% | 328,3 k € | +249% | 94 k € | -17.0% | 113,3 k € | +2530% | 4,3 k € | -84.9% | 28,5 k € | +71.7% | 16,6 k € | -53.8% | 35,9 k € | +1110% | 3 k € |
| EBITDA | 3,1 k € | -81.0% | 16,2 k € | +56744% | -28,6 € | -100% | 10,3 k € | -10.9% | 11,6 k € | -86.5% | 85,6 k € | -14.5% | 100,2 k € | +234% | 30 k € | -87.6% | 240,7 k € | -26.4% | 327,2 k € | +249% | 93,7 k € | -17.0% | 112,9 k € | +3109% | 3,5 k € | -87.5% | 28 k € | +72.2% | 16,3 k € | -54.5% | 35,8 k € | +1213% | 2,7 k € |
| Operating result | 3,1 k € | -81.0% | 16,2 k € | +56744% | -28,6 € | -100% | 10,3 k € | -10.9% | 11,6 k € | -86.5% | 85,6 k € | -14.5% | 100,2 k € | +234% | 30 k € | -87.6% | 240,7 k € | -26.6% | 327,7 k € | +250% | 93,7 k € | -16.7% | 112,4 k € | +3095% | 3,5 k € | -87.4% | 27,9 k € | +77.5% | 15,7 k € | -55.4% | 35,2 k € | +9870% | -360,1 € |
| Net result | 2,1 k € | -88.3% | 18,1 k € | +12188% | -149,6 € | -101% | 10,2 k € | -8.1% | 11,1 k € | -86.9% | 85,1 k € | +1.8% | 83,6 k € | +392% | 17 k € | -90.8% | 185 k € | -24.4% | 244,7 k € | +8444% | 2,9 k € | -59.2% | 7 k € | +267% | 1,9 k € | -90.4% | 19,9 k € | +116% | 9,2 k € | -57.9% | 21,9 k € | +1839% | -1,3 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 257,3 k € | +0.8% | 255,2 k € | +1.1% | 252,3 k € | -0.1% | 252,4 k € | +0.0% | 252,3 k € | +0.0% | 252,2 k € | +0.0% | 252,1 k € | +5.7% | 238,5 k € | +2.1% | 233,5 k € | +38.6% | 168,5 k € | +128% | 73,8 k € | +4.0% | 71 k € | +11.0% | 63,9 k € | +3.1% | 62 k € | +47.4% | 42,1 k € | +28.1% | 32,9 k € | +200% | 10,9 k € |
| Total assets | 258,8 k € | -4.8% | 271,8 k € | +7.1% | 253,8 k € | -3.8% | 264 k € | -0.1% | 264,2 k € | -28.1% | 367,5 k € | -40.4% | 616,3 k € | -49.2% | 1,2 M € | -29.8% | 1,7 M € | -10.9% | 1,9 M € | +58.6% | 1,2 M € | +492% | 206,6 k € | +78.4% | 115,8 k € | +6.1% | 109,1 k € | +52.9% | 71,4 k € | +3.9% | 68,7 k € | +173% | 25,2 k € |
| Cash | 199,7 k € | -13.9% | 232,1 k € | +22.5% | 189,5 k € | -7.7% | 205,3 k € | +16.2% | 176,8 k € | -45.1% | 321,8 k € | +7.9% | 298,2 k € | +539% | 46,7 k € | +293% | 11,9 k € | -54.2% | 25,9 k € | -81.9% | 142,8 k € | – | – | 98,6 k € | +70.2% | 57,9 k € | +11.6% | 51,9 k € | +249% | 14,9 k € | |||
| Debts | 1,4 k € | -91.4% | 16,6 k € | +1017% | 1,5 k € | -87.1% | 11,6 k € | -2.6% | 11,9 k € | -89.7% | 115,3 k € | -68.3% | 364,2 k € | -62.6% | 973,8 k € | -34.8% | 1,5 M € | -15.7% | 1,8 M € | +54.2% | 1,1 M € | +747% | 135,7 k € | +161% | 51,9 k € | +10.2% | 47,1 k € | +60.8% | 29,3 k € | -18.3% | 35,9 k € | +152% | 14,2 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 29/06/2025 · 2 active · 14 ended
Other companies at this address
| Company | CBE no. |
|---|---|
Dr. Maddens● Active | 0765.596.650 |
SODOFIN● Active | 0882.466.507 |
SODOS● Active | 0829.234.885 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 |
| Closing of the financial year | 29/06/2025 | 29/06/2024 | 29/06/2023 | 29/06/2022 | 29/06/2021 | 29/06/2020 |
| Length of the financial year | 13 months | 13 months | 13 months | 13 months | 13 months | 13 months |
| Filing date | 29/01/2026 | 30/01/2025 | 29/01/2024 | 26/01/2023 | 27/01/2022 | 18/01/2021 |
| General meeting | 15/12/2025 | 16/12/2024 | 18/12/2023 | 19/12/2022 | 20/12/2021 | 21/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
18 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 29/06/2025 | 15/12/2025 | 29/01/2026 | Dutch | |
| Micro model | 29/06/2024 | 16/12/2024 | 30/01/2025 | Dutch | |
| Micro model | 29/06/2023 | 18/12/2023 | 29/01/2024 | Dutch | |
| Micro model | 29/06/2022 | 19/12/2022 | 26/01/2023 | Dutch | |
| Micro model | 29/06/2021 | 20/12/2021 | 27/01/2022 | Dutch | |
| Abridged model | 29/06/2020 | 21/12/2020 | 18/01/2021 | Dutch | |
| Abridged model | 29/06/2019 | 16/12/2019 | 30/01/2020 | Dutch | |
| Abridged model | 29/06/2018 | 17/12/2018 | 17/12/2018 | Dutch | |
| Abridged model | 29/06/2017 | 18/12/2017 | 20/12/2017 | Dutch | |
| Abridged model | 29/06/2016 | 19/12/2016 | 27/01/2017 | Dutch | |
| Abridged model | 29/06/2015 | 21/12/2015 | 15/01/2016 | Dutch | |
| Abridged model | 29/06/2014 | 15/12/2014 | 13/01/2015 | Dutch | |
| Abridged model | 29/06/2013 | 16/12/2013 | 14/02/2014 | Dutch | |
| Abridged model | 29/06/2012 | 17/12/2012 | 11/02/2013 | Dutch | |
| Abridged model | 29/06/2011 | 19/12/2011 | 14/02/2012 | Dutch | |
| Abridged model | 30/06/2009 | 21/12/2009 | 29/01/2010 | Dutch | |
| Abridged model | 30/06/2008 | 15/12/2008 | 13/02/2009 | Dutch | |
| Abridged model | 30/06/2007 | 17/12/2007 | 30/01/2008 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Publications
Belgian Official Gazette publications
- Mandates19/10/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
- Registered office02/02/2021MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
- Registered office09/02/2015MAATSCHAPPELIJKE ZETEL
- Mandates25/06/2013ONTSLAGEN - BENOEMINGEN
- Other23/07/2010BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other14/03/2006RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20252,1 k €↓
- 2024Annual accounts 202418,1 k €↑
- 2023Annual accounts 2023-149,6 €↓
- 2022Annual accounts 202210,2 k €↓
- 2020Annual accounts 202011,1 k €↓
- 2019Annual accounts 201985,1 k €↑
- 2018Annual accounts 201883,6 k €↑
- 2017Annual accounts 201717 k €↓
- 2016Annual accounts 2016185 k €↓
- 2015Annual accounts 2015244,7 k €↑
- 2014Annual accounts 20142,9 k €↓
- 2013Annual accounts 20137 k €↑
- 2012Annual accounts 20121,9 k €↓
- 2011Annual accounts 201119,9 k €↑
- 2009Annual accounts 20099,2 k €↓
- 2008Annual accounts 200821,9 k €↑
- 2007Annual accounts 2007-1,3 k €
- 02/03/2006IncorporationPrivate limited company